SCHEMBL15910085

SCHEMBL15910085

CC1=C(C)C(=O)c2c(C)c(C)c(C)c(C)c2C1=O

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.32
NSD2 O96028 1/20 0.32
HSP90AA1 P07900 1/20 0.32
PAX8 Q06710 1/20 0.32
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14791103 0.94
SCHEMBL57098 0.85 TDP2 (0.35) TDP2NSD2HSP90AA1PAX8
SCHEMBL12440737 0.81 TDP2 (0.33) TDP2NSD2HSP90AA1PAX8
SCHEMBL14791105 0.80 DUSP3 (0.44)
SCHEMBL14791104 0.78
SCHEMBL17490275 0.73
SCHEMBL12880823 0.72
SCHEMBL9292686 0.72
Duroquinone SCHEMBL58325 0.71 MAOA (0.38) MAOAMAOB
SCHEMBL14016730 0.69 TDP2 (0.31) TDP2NSD2HSP90AA1PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12576382-B2 Ceramic coating on metal parts to reduce deposit of metallic transition metals in hydrogenation reactions DSM IP ASSETS B.V. (NL) 2026-03-17 US disclosed
US-20230338915-A1 CERAMIC COATING ON METAL PARTS TO REDUCE DEPOSIT OF METALLIC TRANSITION METALS IN HYDROGENATION REACTIONS DSM IP ASSETS B.V. (NL) 2023-10-26 US disclosed
CN-116194204-A Ceramic coating for reducing deposition of metallic transition metals on metal parts in hydrogenation reactions 帝斯曼知识产权资产管理有限公司 2023-05-30 CN disclosed
WO-2022058576-A1 CERAMIC COATING ON METAL PARTS TO REDUCE DEPOSIT OF METALLIC TRANSITION METALS IN HYDROGENATION REACTIONS DSM IP ASSETS B.V. (NL) 2022-03-24 WO disclosed
US-20170003497-A1 ELECTROWETTING ELEMENT LIQUAVISTA B.V. (NL) 2017-01-05 US disclosed
US-9447282-B2 Electrowetting device AMAZON TECHNOLOGIES, INC. (US) 2016-09-20 US disclosed
US-9087996-B2 Fluorine-containing aromatic compound and production method thereof ASAHI GLASS COMPANY, LIMITED (JP) 2015-07-21 US disclosed
US-9012112-B2 Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus CANON KABUSHIKI KAISHA (JP) 2015-04-21 US disclosed
US-20140357873-A1 FLUORINE-CONTAINING AROMATIC COMPOUND AND PRODUCTION METHOD THEREOF AGC Inc. (JP) 2014-12-04 US disclosed
US-20140211293-A1 ELECTROWETTING DEVICE LIQUAVISTA B.V. 2014-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12576382-B2 Ceramic coating on metal parts to reduce deposit of metallic transition metals in hydrogenation reactions CAD, EZH2, ZW10 TDP2 4116/4885NSD2 167/4885HSP90AA1 2036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.